Clinical Trial Update: A Study of Efficacy and Safety of GenSci048 in Subjects With Active Uveitis. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of GenSci048 in active uveitis is not yet recruiting. The sponsor is Changchun GeneScience Pharmaceutical Co.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• GenSci048 (GenSci048)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Uveitis | Phase 2 | Status: NOT_YET_RECRUITING